Completed PHASE4 INTERVENTIONAL 3-arm
NCT01167946
Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata
Sponsor: King Saud University
Interventions
methylprednisolone sodium succinate
Updated 4 times since 2017 Last updated: Jul 21, 2010 Started: Jan 31, 2003 Primary completion: Dec 31, 2009 Completion: Jul 31, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on Alopecia Totalis and Alopecia Universalis, this trial is completed. The trial is conducted by King Saud University and has accumulated 4 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2017 — Jan 2021 [monthly]
Completed PHASE4
First recorded
Jan 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- King Saud University
- Saudi Society of Dermatology and Dermatologic surgery
Data source: King Saud University
For direct contact, visit the study record on ClinicalTrials.gov .